Chronic Kidney Disease as A Potential Risk Factor for Uveitis: A 13-Year Nationwide Population-Based Cohort Study in Taiwan

References

• De Nicola L, Zoccali C. Chronic kidney disease prevalence in the general population: heterogeneity and concerns. Nephrol Dial Transplant. 2016;31(3):331–335. doi:10.1093/ndt/gfv427.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Chronic kidney disease surveillance system website. https://nccd.cdc.gov/CKD. Accessed January 7, 2019.
   Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016; 11(7):e0158765. Published 2016 Jul 6. doi:10.1371/journal.pone.0158765.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Hsu CY, Lin MY, et al. Incidence, prevalence, and duration of chronic kidney disease in Taiwan: results from a community-based screening program of 106,094 individuals. Nephron. 2018;140(3):175–184. doi:10.1159/000491708.
   PubMed Web of Science ®Google Scholar
• Thurman J, Gueler F. Recent advances in renal imaging. F1000Res. 2018;7:F1000Faculty Rev–1867. doi:10.12688/f1000research.16188.1.
   Google Scholar
• Dobrin RS, Vernier RL, Fish AJ. Acute eosinophilic interstitial nephritis and renal failure with bone marrow–lymph node granulomas and anterior uveitis. Am J Med. 1975;59:325–333. doi:10.1016/0002-9343(75)90390-3.
   PubMed Web of Science ®Google Scholar
• Legendre M, Devilliers H, Perard L, et al. Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: a national retrospective strobe-compliant study. Medicine (Baltimore). Jun, 2016;95(26):e3964. PMID: 27367994; PMCID: PMC4937908. doi:10.1097/MD.0000000000003964.
   PubMed Web of Science ®Google Scholar
• Pakzad-Vaezi K, Pepple KL. Tubulointerstitial nephritis and uveitis. Curr Opin Ophthalmol. 2017;28(6):629–635. doi:10.1097/ICU.0000000000000421.
   PubMed Web of Science ®Google Scholar
• Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76(3):137–141. doi:10.1136/bjo.76.3.137.
   PubMed Web of Science ®Google Scholar
• Tien PT, Lin CJ, Tsai YY, et al. Relationship between uveitis, different types of viral hepatitis, and liver cirrhosis: a 12-year nationwide population-based cohort study. Retina. 2016;36(12):2391–2398. doi:10.1097/IAE.0000000000001103.
   PubMed Web of Science ®Google Scholar
• Bertrand PJ, Jamilloux Y, Ecochard R, et al. Uveitis: autoimmunity … and beyond. Autoimmun Rev. 2019;18(9):102351. doi:10.1016/j.autrev.2019.102351.
   PubMed Web of Science ®Google Scholar
• Yang P, Zhong Z, Du L, et al. Prevalence and clinical features of systemic diseases in Chinese patients with uveitis. Br J Ophthalmol. Mar 18, 2020;bjophthalmol-2020-315960. Epub ahead of print. doi:10.1136/bjophthalmol-2020-315960.
   Google Scholar
• Lin CJ, Tien PT, Chang CH, et al. Relationship between uveitis and thyroid disease: a 13-year nationwide population-based cohort study in Taiwan. Ocul Immunol Inflamm. Jul 9, 2020;1-7. ( Epub ahead of print. PMID: 32643974). doi:10.1080/09273948.2020.1762899.
   Google Scholar
• Andy KHL, Vicki L, Matthew AR, Troy LJ. Tubulointerstitial nephritis and uveitis syndrome: sore eyes and sick kidneys. Med J Aust. 2005;183(9):477–478. doi:10.5694/j.1326-5377.2005.tb07128.x.
   PubMed Web of Science ®Google Scholar
• Mansour AM. Ocular manifestations of various systemic diseases. Curr Opin Ophthalmol. 1996;7(6):96–98. doi:10.1097/00055735-199612000-00016.
   PubMedGoogle Scholar
• Wong CW, Wong TY, Cheng CY, Sabanayagam C. Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. Kidney Int. 2014;85(6):1290–1302. doi:10.1038/ki.2013.491.
   PubMed Web of Science ®Google Scholar
• Steven S, Frenis K, Oelze M, et al., Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. Jun 23, 2019;2019:7092151. PMID: 31341533; PMCID: PMC6612399. doi:10.1155/2019/7092151.
   PubMed Web of Science ®Google Scholar
• Escoli R, Oliveira R, Santos P, Lobos AV. Kidney diseases with ocular involvement: a systematic review. Port J Nephrol Hypertens. 2018;32(3):268–278.
   Google Scholar
• Gao B, Zhu L, Pan Y, Yang S, Zhang L, Wang H. Ocular fundus pathology and chronic kidney disease in a Chinese population. BMC Nephrol. 2011;12:62. doi:10.1186/1471-2369-12-62.
   PubMed Web of Science ®Google Scholar
• Grunwald JE, Alexander J, Ying GS, et al.; CRIC Study Group. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol. 2012;130:1136–1144. doi:10.1001/archophthalmol.2012.1800.
   PubMed Web of Science ®Google Scholar
• Wang TJ, Wu CK, Hu CC, Keller JJ, Lin HC. Increased risk of co-morbid eye disease in patients with chronic renal failure: a population-based study. Ophthalmic Epidemiol. 2012;19(3):137–143. doi:10.3109/09286586.2012.680531.
   PubMed Web of Science ®Google Scholar
• Oberg BP, McMenamin E, Lucas FL, et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 2004;65(3):1009–1016. doi:10.1111/j.1523-1755.2004.00465.x.
   PubMed Web of Science ®Google Scholar
• Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;74(111):S4–9. doi:10.1038/ki.2008.516.
   Google Scholar
• Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92. doi:10.1159/000368940.
   PubMed Web of Science ®Google Scholar
• Machowska A, Carrero JJ, Lindholm B, Stenvinkel P. Therapeutics targeting persistent inflammation in chronic kidney disease. Transl Res. 2016;167(1):204–213. doi:10.1016/j.trsl.2015.06.012.
   PubMed Web of Science ®Google Scholar
• Anders HJ. 2019 update in basic kidney research: microbiota in chronic kidney disease, controlling autoimmunity, kidney inflammation and modelling the glomerular filtration barrier. Nephrol Dial Transplant. 2020;35(1):4–9. doi:10.1093/ndt/gfz219.
   PubMed Web of Science ®Google Scholar
• Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci. 2019;21(1):263. doi:10.3390/ijms21010263.
   PubMed Web of Science ®Google Scholar
• Park HC, Lee YK, Cho A, et al. Diabetic retinopathy is a prognostic factor for progression of chronic kidney disease in the patients with type 2 diabetes mellitus. PLoS One. 2019;14(7):e0220506. Published 2019 Jul 29. doi:10.1371/journal.pone.0220506.
   PubMed Web of Science ®Google Scholar
• Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat Rev Nephrol. 2018;14:361–377. doi:10.1038/s41581-018-0001-y.
   PubMed Web of Science ®Google Scholar
• Botdorf J, Chaudhary K, Whaley-Connell A. Hypertension in cardiovascular and kidney disease. Cardiorenal Med. 2011;1:183–192. doi:10.1159/000329927.
   PubMed Web of Science ®Google Scholar
• Segura J, Ruilope L. Hypertension in moderate-to-severe nondiabetic CKD patients. Adv Chronic Kidney Dis. 2011;18:23–27. doi:10.1053/j.ackd.2010.11.001.
   PubMed Web of Science ®Google Scholar
• Bidani AK, Polichnowski AJ, Loutzenhiser R, Griffin KA. Renal microvascular dysfunction, hypertension and CKD progression. Curr Opin Nephrol Hypertens. 2013;22(1):1–9. doi:10.1097/MNH.0b013e32835b36c1.
   PubMed Web of Science ®Google Scholar
• Kaysen GA. Hyperlipidemia in chronic kidney disease. Int J Artif Organs. 2007;30(11):987–992. doi:10.1177/039139880703001107.
   PubMed Web of Science ®Google Scholar
• Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J Gerontol A Biol Sci Med Sci. 2010;65:963–975. doi:10.1093/gerona/glq074.
   PubMed Web of Science ®Google Scholar
• Rajendran P, Rengarajan T, Thangavel J, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9:1057–1069. doi:10.7150/ijbs.7502.
   PubMed Web of Science ®Google Scholar
• Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang I. Diabetic retinopathy in patients with diabetic nephropathy: development and progression. PLoS ONE. 2016;11(8):e0161897. doi:10.1371/journal.pone.0161897.
   PubMed Web of Science ®Google Scholar
• Rothova A, Meenken C, Michels RP, Kijlstra A. Uveitis and diabetes mellitus. Am J Ophthalmol. 1988;106(1):17–20. doi:10.1016/S0002-9394(14)76381-0.
   PubMed Web of Science ®Google Scholar
• Ansari AS, de Lusignan S, Hinton W, Munro N, Taylor S, McGovern A. Glycemic control is an important modifiable risk factor for uveitis in patients with diabetes: a retrospective cohort study establishing clinical risk and ophthalmic disease burden. J Diabetes Complications. 2018;32(6):602–608. doi:10.1016/j.jdiacomp.2018.03.008.
   PubMed Web of Science ®Google Scholar
• Kheir WJ, Sheheitli HA, Hamam RN. Intraocular inflammation in diabetic populations. Curr Diab Rep. Aug 8, 2017;17(10):83. doi:10.1007/s11892-017-0910-3.
   PubMed Web of Science ®Google Scholar
• Oswal KS, Sivaraj RR, Murray PI, Stavrou P. Clinical course and visual outcome in patients with diabetes mellitus and uveitis. BMC Res Notes. Apr 29, 2013;6:167. doi:10.1186/1756-0500-6-167.
   PubMedGoogle Scholar
• Talat L, Tomkins-Netzer O, Taylor SR, et al. The influence of diabetes mellitus on the management and visual outcome of patients with uveitis. Acta Ophthalmol. Jun, 2014;92(4):e329–30. doi:10.1111/aos.12313.
   PubMed Web of Science ®Google Scholar
• Shapiro MD, Fazio S. From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circ Res. 2016;118(4):732–749. doi:10.1161/CIRCRESAHA.115.306471.
   PubMed Web of Science ®Google Scholar
• Pacia MZ, Sternak M, Mateuszuk L, Stojak M, Kaczor A, Chlopicki S. Heterogeneity of chemical composition of lipid droplets in endothelial inflammation and apoptosis. Biochim Biophys Acta Mol Cell Res. Feb 18, 2020;118681. ( Epub ahead of print). doi:10.1016/j.bbamcr.2020.118681.
   Google Scholar
• Borkar DS, Tham VM, Shen E, et al. Association between statin use and uveitis: results from the Pacific ocular inflammation study. Am J Ophthalmol. 2015;159(4):707–713. doi:10.1016/j.ajo.2015.01.009.
   PubMed Web of Science ®Google Scholar
• Al-Janabi A, Lightman S, Tomkins-Netzer O. Statins in retinal disease. Eye (Lond). 2018;32(5):981–991. doi:10.1038/s41433-018-0066-7.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867. doi:10.1038/nature05485.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–185. doi:10.1038/nature21363.
   PubMed Web of Science ®Google Scholar
• Ridker PM. Hyperlipidemia as an instigator of inflammation: inaugurating new approaches to vascular prevention. J Am Heart Assoc. 2012;1(1):3–5. doi:10.1161/xJAHA.112.000497.
   PubMed Web of Science ®Google Scholar
• van der Heijden RA, Bijzet J, Meijers WC, et al. Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis. Sci Rep. 2015;5:16474. doi:10.1038/srep16474.
   PubMed Web of Science ®Google Scholar
• Cheon SY, Chung KS, Lee KJ, et al. HVC1 ameliorates hyperlipidemia and inflammation in LDLR−/- mice. BMC Complement Altern Med. 2017;17(1):222. doi:10.1186/s12906-017-1734-z.
   PubMedGoogle Scholar
• Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature. 1997;389(6651):610–614. doi:10.1038/39335.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Sakamoto S, Takeuchi M, et al. Association between smoking and patients with uveitis in Japan. Invest Ophthalmol Vis Sci. 2008;49:3905.
   Google Scholar
• Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology. 2010;117(3):585–590. doi:10.1016/j.ophtha.2009.08.011.
   PubMed Web of Science ®Google Scholar
• Yuen BG, Tham VM, Browne EN, et al. Association between smoking and uveitis: results from the Pacific ocular inflammation study. Ophthalmology. 2015;122(6):1257–1261. doi:10.1016/j.ophtha.2015.02.034.
   PubMed Web of Science ®Google Scholar
• Gonçalves RB, Coletta RD, Silvério KG, et al. Impact of smoking on inflammation: overview of molecular mechanisms. Inflamm Res. 2011;60(5):409–424. doi:10.1007/s00011-011-0308-7.
   PubMed Web of Science ®Google Scholar
• Sarir H, Mortaz E, Karimi K, et al. Cigarette smoke regulates the expression of TLR4 and IL-8 production by human macrophages. J Inflammation. 2009;6(1):12. doi:10.1186/1476-9255-6-12.
   Google Scholar